A $44 million VC infusion in 2017 for biosciences firm On Target Laboratories was one indication that Indiana’s life sciences sector is finally starting to pull down some serious venture funding.
The 30-acre first phase of the 16 Tech innovation district, long touted as an up-and-coming hub for entrepreneurship and innovation, will be spurred by a $120 million investment from Browning and a $38 million grant from Lilly Endowment.
Its $1.5 million investment is expected to help B2S Life Sciences more than double its staff and grow its client base, which includes contract research groups, pharmaceutical firms and biotech startups.
The agricultural spinoff includes the Indianapolis operations of the former Dow AgroSciences headquarters, which employs about 1,500.
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
OrthoPediatrics Corp. raised $52 million on Oct. 12, and Carmel-based Merchants Bancorp raised $115 million on Oct. 27.
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
The bill that President Donald Trump signed Monday night to reopen the federal government included a two-year delay in implementing a tax on medical devices, bringing praise from Indiana-based Cook Group.
The Agribusiness Council of Indiana has merged with the Indiana Seed Trade Association, the associations announced Wednesday.
One of the Indianapolis-area’s largest private companies is taking on a different name to better reflect its mission in livestock health.
The 2.3 percent federal excise tax on medical device manufacturers originally imposed in 2013 as one of several taxes and fees in the Affordable Care Act
The 5-year-old Carmel biotech has won plenty of attention from Wall Street and has secured more than $100 million through licensing deals and a stock offering to help fund expensive clinical trials.
Hill-Rom Holdings Inc., which owns Tridien Medical, said it plans to begin eliminating employees Jan. 31 with terminations continuing until Sept. 30, when the facility will permanently close.
A company founded a year ago by prominent local tech entrepreneur Don Brown expects to pay average salaries of $156,000 a year in new space at the IU Emerging Technology Center.
The suit names two dozen entities, including Stamford, Connecticut-based Purdue Pharma LP—which produces OxyContin—as well as Cephalon Inc, Teva Pharmaceutical Industries Ltd., Johnson & Johnson and Janssen Pharmaceuticals.
AgriNovus Indiana wants to get the word out on the state’s agbiosciences efforts and the opportunities they offer across several agricultural and technological sectors.
The company said the funds would help it test its lead compound in late-stage clinical trials, allowing surgeons to detect cancerous cells with the help of fluorescent dyes.
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
Cook officials cast the sale of Cook Pharmica and the purchase of what once was the world’s largest refrigerator factory as good news for Bloomington.
